Loading viewer...
conference
Format: PDF conference
Miragen Therapeutics presented its RNA-targeted therapeutic pipeline focused on correcting microRNA dysregulation to treat disease. The clinical-stage biopharmaceutical company discussed initial 2016 clinical data from MRG-106 in hematological malignancies and MRG-201 in cutaneous fibrosis, following a progressive de-risking strategy in early trials.
presentation
conference
10 Pages
Intel
Calumet Specialty Products 2023 Bank of America Leveraged Finance
conferenceconference
21 Pages
Calumet Specialty Products Partners
Summit Wireless (WISA) 2021 Rocky Mountain Microcap Conference Presentation
conferenceconference
24 Pages
Summit Wireless Technologies, Inc.